Duodenal Follicular Lymphoma: Track or Treat?

被引:2
作者
Varanese, M. [1 ]
Lauro, A. [1 ]
Lattina, I [1 ]
Tripodi, D. [1 ]
Daralioti, T. [2 ]
Khouzam, S. [3 ]
Marino, I. R. [3 ]
Stigliano, V [2 ]
D'Andrea, V [1 ]
Frattaroli, S. [1 ]
Sorrenti, S. [1 ]
机构
[1] Sapienza Univ, Dept Surg Sci, Rome, Italy
[2] IRCCS Regina Elena Natl Canc Inst, Gastroenterol & Digest Endoscopy, Rome, Italy
[3] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
关键词
Follicular lymphoma; Duodenum; Chemoimmunotherapy; Literature review; RITUXIMAB;
D O I
10.1007/s10620-022-07498-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Duodenal follicular lymphoma (DFL) is a rare variety of non-Hodgkin's lymphoma of the gastrointestinal tract that usually carries a favorable course, recognized as a new entity in 2016. It is usually diagnosed at an early stage located predominantly in the second portion of the duodenum. We report the case of a 74-year-old male patient with epigastric pain in whom gastroscopy revealed white mucosal nodules that were pathologically diagnosed as grade 1-2 DFL. Staging investigations revealed secondary lesions in the spleen and at the base of the tongue together with latero-cervical adenopathy. The tumor was stage IV according to the Lugano staging system. We reviewed the recent (last five years) literature defining the importance of combination therapy in the advanced stage. The patient achieved complete remission of the disease through chemoimmunotherapy following the Rituximab-Bendamustine scheme.
引用
收藏
页码:1733 / 1738
页数:6
相关论文
共 50 条
  • [41] Current controversies in follicular lymphoma
    Aurora, Vikas
    Winter, Jane N.
    [J]. BLOOD REVIEWS, 2006, 20 (04) : 179 - 200
  • [42] Immunomodulatory Agents in Follicular Lymphoma
    Ysebaert, Loic
    Morschhauser, Franck
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (04) : 715 - +
  • [43] Rituximab in the treatment of follicular lymphoma
    Jurczak, Wojciech
    Walewski, Jan
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (03): : 117 - 126
  • [44] Rituximab for the treatment of follicular lymphoma
    Cheah, Chan Y.
    Lingaratnam, Senthil
    Seymour, John F.
    [J]. FUTURE ONCOLOGY, 2013, 9 (09) : 1283 - 1298
  • [45] Primary gastrointestinal follicular lymphoma
    Liu, Xiao-Mei
    Xu, Zhong
    Wang, Hai-Xing
    Huang, Wei-Feng
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (01)
  • [46] Diagnosis and treatment of follicular lymphoma
    Hitz, Felicitas
    Ketterer, Nicolas
    Lohri, Andreas
    Mey, Ulrich
    Pederiva, Stefanie
    Renner, Christoph
    Taverna, Christian
    Hartmann, Anna
    Yeow, Karen
    Bodis, Stephan
    Zucca, Emanuele
    [J]. SWISS MEDICAL WEEKLY, 2011, 141
  • [47] What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options
    Duffles Amarante, Guilherme
    Collins, Graham
    Rocha, Vanderson
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : 831 - 837
  • [48] Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
    Li, Ru
    Wang, Tingyu
    Lyv, Rui
    Wang, Yi
    Yu, Ying
    Yan, Yuting
    Sun, Qi
    Xiong, Wenjie
    Liu, Wei
    Sui, Weiwei
    Huang, Wenyang
    Wang, Huijun
    Li, Chengwen
    Wang, Jun
    Zou, Dehui
    An, Gang
    Wang, Jianxiang
    Qiu, Lugui
    Yi, Shuhua
    [J]. BLOOD SCIENCE, 2023, 5 (02): : 118 - 124
  • [49] Management of patients with follicular lymphoma treated first line with obinutuzumab
    Opat, Stephen
    Dickinson, Michael
    Cheah, Chan Yoon
    Tam, Constantine
    Boulos, Joy
    Thorburn, Alison Nicole
    Trotman, Judith
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 3 - 11
  • [50] Follicular lymphoma
    Ghielmini, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 151 - 153